gw8510 has been researched along with Trypanosomiasis, African in 1 studies
GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source
Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ojo, KK | 1 |
| Gillespie, JR | 1 |
| Riechers, AJ | 1 |
| Napuli, AJ | 1 |
| Verlinde, CL | 1 |
| Buckner, FS | 1 |
| Gelb, MH | 1 |
| Domostoj, MM | 1 |
| Wells, SJ | 1 |
| Scheer, A | 1 |
| Wells, TN | 1 |
| Van Voorhis, WC | 1 |
1 other study available for gw8510 and Trypanosomiasis, African
| Article | Year |
|---|---|
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
Topics: Animals; Base Sequence; DNA Primers; DNA, Protozoan; Genes, Protozoan; Glycogen Synthase Kinase 3; H | 2008 |